Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-marketing safety evaluation of Imrecoxib in osteoarthritis
ChiCTR-OPC-16008157Phase 4Not yet recruiting
- Sponsor
- Puyang Oilfield General Hospital
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imrecoxib in knee osteoarthritis (OA), sponsored by Puyang Oilfield General Hospital. Planned start Apr 2016; status: not yet recruiting.
02
Drugs
imrecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR-OPC-16008157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPC-16008157.